Allurion Technologies Inc (NYSE:ALUR) has made significant progress in the FDA approval process for the Euron smart capsule, passing several critical milestones without any observations or Form 483 ...
Allurion shares slipped after it priced a discounted warrant exercise expected to raise about $3 million and add potential dilution.
Warrants to purchase 0.056818 shares of common stock, each at an exercise price of $202.50 per share of common stock Expand The Exchange previously announced on March 2, 2026 that the Company was no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results